AVIR
Atea Pharmaceuticals Inc
5.20$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -99.4% | +0.0% | +0.0% | +19,056.7% | -99.5% | +3,207.7% | -29.7% | +1,480.6% | -99.7% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.8% | +64.3% | -39.7% | -24.6% | -1.9% | +15.2% | +9.1% | +18.8% | +24.7% | -14.0% | -31.6% | – | |
| – | -8.5% | +6.1% | -0.1% | -9.6% | +20.9% | -29.2% | -4.1% | -20.4% | -1.4% | -3.4% | +1.1% | – | |
| – | +104.5% | +50.0% | -32.8% | -63.1% | +125.3% | -8.5% | +9.3% | -81.2% | +649.1% | -12.8% | -26.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +57.9% | -33.8% | +5.2% | -7.0% | -0.4% | -9.8% | +2.0% | -5.3% | -3,553.1% | – | -52.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.